Source: Annual Congress 2010 - COPD and asthma: models and human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sobradillo, R. Faner, A. Agustí, E. Ballester, N. Soler, J. Yagüe, M. Juan, J. I. Aróstegui (Barcelona, Spain). Caspase-1 pathway in COPD. Eur Respir J 2010; 36: Suppl. 54, 1999

Member's Comments

No comment yet.

Related content which might interest you: Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Activation of IL-32 pathway in COPD Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020 Year: 2020 The inflammasome pathway in stable COPD and acute exacerbations Source: ERJ Open Res 2016: 00002-2016 Year: 2016 A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Hedgehog pathway activation is altered in COPD patients Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Notch pathway signaling in asthma Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1 Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Role of the kinase-dependent functions of RIPK1 in COPD Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Elevated expression of the NLRP3 inflammasome in neutrophilic asthma Source: Eur Respir J 2014; 43: 1067-1076 Year: 2014 Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019 Year: 2020 Role of necroptosis in the pathogenesis of COPD Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 The NLRP3 inflammasome in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: experimental biology Year: 2013